Skip to content
Equity Capital Market
  • Privacy Policy
  • Start Here
  • Research
    • LPTH case study
    • PLUG case study
    • STDN case study
  • IPO & Public Offerings
  • Economy & Macro
  • Latest
  • Stock Market
  • Market Education
  • Energy & Commodities
  • Capital Markets
  • Federal Reserve & Rates
  • About
  • Contact

halo stock

Halozyme Inks $1.5B Convertible Debt Deal and Capped Calls

September 23, 2026 by Bruno M.
AI-generated editorial image: Minimalist executive boardroom table with corporate finance portfolio binder in morning natural light

Halozyme closed a $1.5B convertible debt offering with capped calls, refinancing 2027 and 2028 notes while securing over $630M in fresh liquidity.

Categories IPO & Public Offerings, Market Education Tags capital markets, capped calls, convertible notes, debt refinancing, halo stock, halozyme therapeutics

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

  • Start Here
  • Market Education
  • Stock Market
  • Capital Markets
  • Federal Reserve & Rates

Recent Posts

  • Bank of America Hit With $1.2B Penalty Over AML Failures
  • UnitedHealth Lifts 2026 Outlook as Q3 Operating Profit Jumps 52%
  • How to Read the CFTC Commitments of Traders (COT) Report
  • Live Nation Prices Dual-Currency Notes With Cross-Currency Swap
  • Albertsons Seeks $9.3B From Kroger as Deal Fight Heads to Trial

Subscribe to Our Newsletter

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

  • Privacy Policy
  • Editorial Policy
  • Corrections Policy
  • Financial Disclaimer
  • Contact
  • About Bruno M.
  • Investor Tools
© 2026 Equity Capital Market • Built with GeneratePress